Joke M. Koelewijn

Effect of screening for red cell antibodies, other than anti‐D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands

Joke M. Koelewijn, Tanja G. M. Vrijkotte, C. Ellen van der Schoot et al. · Transfusion · 2008 · 234 citations

One single dose of 200 μg of antenatal RhIG halves the risk of anti‐D immunization and hemolytic disease of the fetus and newborn in the next pregnancy

Joke M. Koelewijn, Masja de Haas, Tanja G. M. Vrijkotte et al. · Transfusion · 2008 · 115 citations

Glycosylation pattern of anti‐platelet IgG is stable during pregnancy and predicts clinical outcome in alloimmune thrombocytopenia

Myrthe E. Sonneveld, Suvi Natunen, Susanna Sainio et al. · British Journal of Haematology · 2016 · 97 citations

Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management

Yolentha M. Slootweg, Irene T.M. Lindenburg, Joke M. Koelewijn et al. · American Journal of Obstetrics and Gynecology · 2018 · 69 citations · Full text

Neonatology, Anti-kell-mediated Hemolytic Disease, Laboratory Hematology +12

Antigen specificity determines anti‐red blood cell IgG‐Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn

Myrthe E. Sonneveld, Joke M. Koelewijn, Masja de Haas et al. · British Journal of Haematology · 2016 · 59 citations · Full text